Literature Review: The Significance of Epstein-Barr Virus and Latent Membrane Protein 1 (LMP-1) Detection and Their Clinical Implications in Nasopharyngeal Carcinoma

Nasopharyngeal carcinoma (NPC), a type of epithelial cancer, is frequently found in Southeast Asia and Southern China. The Epstein-Barr Virus (EBV) significantly contributes to the development of NPC by producing latent proteins, particularly Latent Membrane Protein 1 (LMP-1). This protein acts as an oncoprotein, activating several signaling pathways, including NF-κB, JAK/STAT, and PI3K/Akt. Consequently, this factor facilitates cellular proliferation, angiogenesis, and the inhibition of apoptosis. A multitude of investigations have established a correlation between the expression of LMP-1 and both the malignancy of tumors and the clinical outcomes of individuals afflicted with KNF. LMP-1 detection can be achieved through immunohistochemistry (IHC), polymerase chain reaction (PCR), or in situ hybridization (ISH) techniques, each exhibiting varying degrees of sensitivity and specificity. Furthermore, LMP-1 serves as a critical diagnostic and prognostic indicator, and it also presents a potential target for molecular interventions in nasopharyngeal cancer.